Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Carbachol
Drug ID BADD_D00355
Description Carbamoylcholine, also known as carbachol, is a muscarinic agonist discovered in 1932.[A226315] Carbamoylcholine was initially used as a treatment for migraines,[A226365] induction of diuresis,[A226370] and other parasympathetic effects. Carbamoylcholine was granted FDA approval on 28 September 1972.[L30245]
Indications and Usage Primarily used in the treatment of glaucoma, but is also used during ophthalmic surgery.
Marketing Status Prescription; Discontinued
ATC Code N07AB01; S01EB02
DrugBank ID DB00411
KEGG ID D00524
MeSH ID D002217
PubChem ID 5831
TTD Drug ID D0U7BW
NDC Product Code 0065-0023
Synonyms Carbachol | Carbocholine | Carbacholine | Miostat | Jestryl | Carbamann | Doryl | Carbastat | Carboptic | Isopto Carbachol | Carbachol, Isopto | Carbamylcholine | Carbamoylcholine
Chemical Information
Molecular Formula C6H15N2O2.Cl
CAS Registry Number 51-83-2
SMILES C[N+](C)(C)CCOC(=O)N.[Cl-]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
BradycardiaMuscarinic acetylcholine receptor M2P08172T4618511181912; 10323282; 9884068; 10336509
Hormone level abnormalMuscarinic acetylcholine receptor M3P20309T6768411165048; 10556783; 7588377
HyperglycaemiaPro-glucagonP06883Not Available2863911; 2876643; 2873022; 2101322; 2904767; 1681438; 6146542; 2563682; 2891576; 2574406
Hypothalamus and pituitary gland disordersCytochrome c oxidase subunit 1P00395Not Available12369741; 12510868; 11785775; 14726617
Hypothalamus and pituitary gland disordersProstaglandin E2 receptor EP1 subtypeQ9BGL8Not Available12369741; 12510868; 11785775; 14726617
SeizureProtein c-FosP01100T2802511074189; 14667462; 8925273
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Arrhythmia02.03.02.001--Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Bladder discomfort20.02.02.019--Not Available
Ciliary muscle spasm17.17.02.002; 06.05.03.001--Not Available
Corneal degeneration06.06.03.001--Not Available
Corneal opacity06.06.03.005--Not Available
Diarrhoea07.02.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dyspepsia07.01.02.001--
Eye irritation06.04.05.003--Not Available
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
Headache17.14.01.001--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypotension24.06.03.002--
Iritis10.02.01.022; 06.04.03.002--Not Available
Loss of consciousness17.02.04.004--Not Available
Muscle spasms15.05.03.004--
Pain08.01.08.004--
Retinal detachment12.01.04.004; 06.09.03.003--
Salivary hypersecretion07.06.01.009--Not Available
Shock24.06.02.002--Not Available
Syncope02.01.02.008; 24.06.02.012; 17.02.04.008--
Vomiting07.01.07.003--
Conjunctival hyperaemia06.04.01.004--Not Available
The 1th Page    1    Total 1 Pages